首頁/生物相似藥Polpharma Biologics 攜手阿根廷藥廠 拓展拉美自體免疫藥物市場三星生物製藥進軍日本！乾癬生物相似藥正式納入健保給付癌症患者新希望！三星生物製劑Keytruda生物相似藥一期臨床達標1
%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20mask:%20url(%23mask);%20}%20.st1%20{%20fill:%20%23fff;%20}%20.st1,%20.st2%20{%20fill-rule:%20evenodd;%20}%20.st3%20{%20mask:%20url(%23mask-1);%20}%20.st2%20{%20fill:%20%235189a0;%20}%20%3c/style%3e%3cmask%20id='mask'%20x='0'%20y='0'%20width='20.8'%20height='20.8'%20maskUnits='userSpaceOnUse'%3e%3cg%20id='mask-2'%3e%3cpolygon%20id='path-1'%20class='st1'%20points='0%200%2020.8%200%2020.8%2020.8%200%2020.8%200%200'/%3e%3c/g%3e%3c/mask%3e%3cmask%20id='mask-1'%20x='16.2'%20y='15.8'%20width='7.4'%20height='7.4'%20maskUnits='userSpaceOnUse'%3e%3cg%20id='mask-4'%3e%3cpolygon%20id='path-3'%20class='st1'%20points='16.2%2015.8%2023.6%2015.8%2023.6%2023.1%2016.2%2023.1%2016.2%2015.8'/%3e%3c/g%3e%3c/mask%3e%3c/defs%3e%3cg%20id='web版'%3e%3cg%20id='_內文頁'%20data-name='內文頁'%3e%3cg%20id='btn_search'%3e%3cg%20id='Group-3'%3e%3cg%20class='st0'%3e%3cpath%20id='Fill-1'%20class='st2'%20d='M10.4,3c-4.1,0-7.4,3.3-7.4,7.4s3.3,7.4,7.4,7.4,7.4-3.3,7.4-7.4-3.3-7.4-7.4-7.4M10.4,20.8C4.7,20.8,0,16.1,0,10.4S4.7,0,10.4,0s10.4,4.7,10.4,10.4-4.7,10.4-10.4,10.4'/%3e%3c/g%3e%3c/g%3e%3cg%20id='Group-6'%3e%3cg%20class='st3'%3e%3cpath%20id='Fill-4'%20class='st2'%20d='M23.1,22.3l-.4.4c-.6.6-1.7.6-2.3,0l-3.7-3.7c-.6-.6-.6-1.7,0-2.3l.4-.4c.6-.6,1.7-.6,2.3,0l3.7,3.7c.6.6.6,1.7,0,2.3'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
